Standout Papers
Citation Impact
Citing Papers
Long‐term clinical outcome of Helicobacter pylori eradication for gastric mucosa‐associated lymphoid tissue lymphoma with a reference to second‐line treatment
2005
Corpus gastritis is protective against reflux oesophagitis
1999
Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low
2000
Opposing time trends of peptic ulcer and reflux disease
1998
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Ageing populations: the challenges ahead
2009 Standout
Hepatocellular carcinoma
2003 Standout
Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin Use
2002 Standout
Systematic review and meta‐analysis: is 1‐week proton pump inhibitor‐based triple therapy sufficient to heal peptic ulcer?
2005
Long-Term Remission of Chronic Hepatitis B after Alpha-Interferon Therapy
1991
Inflammation and cancer
2002 StandoutNature
Helicobacter mustelae-associated Gastric Adenocarcinoma in Ferrets (Mustela putorius furo)
1997
Synergism of chronic alcoholism and hepatitis B infection in liver disease
1989
Liver fibrosis
2005 Standout
The value of wireless capsule endoscopy in patients with complicated celiac disease
2005
Survival after the Age of 80 in the United States, Sweden, France, England, and Japan
1995
Sjögren's syndrome
2005 Standout
The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease
2008
Rising Incidence of Hepatocellular Carcinoma in the United States
1999 Standout
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium
2007 StandoutNobel
Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan
2002
Hepatocellular carcinoma with and without cirrhosis
1989
Helicobacter pylori and gastric diseases
1998
Management of hepatitis B: 2000—Summary of a workshop
2001
Coeliac disease
2003
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA
1989 StandoutNobel
Lewis enzyme (α1–3/4 fucosyltransferase) polymorphisms do not explain the Lewis phenotype in the gastric mucosa of a Portuguese population
2003
An investigation into factors associated with Helicobacter pylori infection
2000
A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive chinese children
1988
Involvement of chemokine receptors in breast cancer metastasis
2001 StandoutNature
Helicobacter Pylori: Epidemiology and Routes of Transmission
2000
Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders
2009 Standout
Helicobacter pylori Adhesins: Review and Perspectives
2000
Hepatitis B virus infection
2009 Standout
Rapid eradication of Helicobacter pylori infection
1995
Natural history of chronic HBV infection: A cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project)
2005
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Dyspepsia management in primary care: A decision analysis of competing strategies
2002
Celiac Disease
2007 Standout
Lymphocyte Trafficking and Regional Immunity
1999
Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue
2005
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences
2013 Standout
Multiple Oligomeric States of the Helicobacter pylori Vacuolating Toxin Demonstrated by Cryo-electron Microscopy
2002 StandoutNobel
Helicobacter pylori Infection and the Development of Gastric Cancer
2001 Standout
Mosaicism in Vacuolating Cytotoxin Alleles of Helicobacter pylori
1995
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection
1995
Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma
2005
The molecular basis of copper-transport diseases
2001
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Helicobacter pylori: microbiology of a ‘slow’ bacterial infection
1993
Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts
2003
The biochemistry and medical significance of the flavonoids
2002 Standout
Relationship between the birth cohort pattern of Helicobacter pylori infection and the epidemiology of duodenal ulcer
2002
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
1996 Standout
Inflammatory Bowel Disease
2002 Standout
Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease
1995
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
Effect of Pretreatment Antibiotic Resistance to Metronidazole and Clarithromycin on Outcome of Helicobacter pylori Therapy
2000
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
2006 Standout
Chronic hepatitis B
2007 Standout
Lipid peroxidation and irreversible damage in the rat hepatocyte model
1992
Induction of gastric ulcer and intestinal metaplasia in Mongolian gerbils infected withHelicobacter pylori
1996
Helicobacter pylori Infection and Gastric Lymphoma
1994 Standout
Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue
2001
Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection
1998
Symptomatic Benefit from EradicatingHelicobacter pyloriInfection in Patients with Nonulcer Dyspepsia
1998
Risk of malignancy in patients with celiac disease
2003
Helicobacter pyloriInfection
2010
Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double‐blind trial
1995
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Age-Specific Incidence of Helicobacter pylori
2006
Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis
2000
Gold‐Catalyzed Regioselective Synthesis of 2‐ and 3‐Alkynyl Furans
2013
Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method
2000
Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein
1994
Helicobacter pyloriReinfection Is Virtually Absent after Successful Eradication
1997
H pylori colocalises with MUC5AC in the human stomach
2000
Helicobacter pyloriInfection
2002 Standout
Antibiotic resistance in : Implications for therapy
1998
Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis
1998
Milk Thistle ( Silybum marianum ) for the Therapy of Liver Disease
1998 Standout
Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report
2002
Low rates of Helicobacter pylori reinfection in children
1999
Genotyping of Helicobacter pylori isolates by sequencing of PCR products and comparison with the RAPD technique
1996
Bleeding Peptic Ulcer
1994 Standout
Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma
1990 StandoutNobel
Comparative Treatment of Helicobacter pylori–Positive Duodenal Ulcer Using Pantoprazole at Low and High Doses Versus Omeprazole in Triple Therapy
1999
Translating an Understanding of the Pathogenesis of Hepatic Fibrosis to Novel Therapies
2013
Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series
2003
The MUC5AC Glycoprotein is the Primary Receptor for Helicobacter pylori in the Human Stomach
2003
Prospective Study of Hepatocellular Carcinoma and Liver Cirrhosis in Asymptomatic Chronic Hepatitis B Virus Carriers
1997
Insufficient diagnostic accuracy of imported serological kits for Helicobacter pylori infection in Japanese population
2000
Symptomatic benefit 1-3 years after h. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease
2000
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Update on therapeutic options for Helicobacter pylori-related diseases
2005
Chronic liver injury, TGF-β, and cancer
2001
Hepatocellular carcinoma
2022 Standout
Immunophenotyping in the management of gastric lymphoma
1991
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
2000 StandoutNature
The human microbiome: at the interface of health and disease
2012 Standout
HEPATIC FIBROSIS
2001
Gastric Function in Dogs with Naturally Acquired Gastric Helicobacter spp. Infection
1999
Quercetin and myricetin protect against hydrogen peroxide-induced DNA damage (strand breaks and oxidised pyrimidines) in human lymphocytes
1997
Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection
1997
The gastric marginal zone B-cell lymphoma of MALT type
2000
Antimicrobial Therapies for Helicobacter pylori Infection in Gnotobiotic Piglets
1998
Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk.
1995
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: A prospective study
1991
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
2007 StandoutNobel
Serologic detection of infection with cagA+ Helicobacter pylori strains
1995
Gastric Ulcer, Atrophic Gastritis, and Intestinal Metaplasia Caused byHelicobacter pyloriInfection in Mongolian Gerbils
1998
cag , a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors
1996 Standout
Review article:Helicobacter pyloriand gastro‐oesophageal reflux disease—clinical implications and management
1999
Unrevealing the natural course of the so-called “inactive HBsAg or HBV carrier state”
2007
Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity
2003
Eradication ofHelicobacter pylori
1996
Helicobacter pylori gastritis and primary gastric non-Hodgkin's lymphomas.
1994
Occurrence of gastric ulcers in gnotobiotic piglets colonized by Helicobacter pylori
1995
High Levels of Resistance to Metronidazole and Clarithromycin in Helicobacter pylori Strains in Children
2001
Hepatocellular Carcinoma
1988
Recurrent symptoms and gastro‐oesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection
2000
Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients
1991
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Relationships between nutrition, alcohol use, and liver disease.
2003
Fluorescent Sensors for Measuring Metal Ions in Living Systems
2014 Standout
Hepatocellular Carcinoma versus Other Hepatic Malignancy in Cirrhosis: Performance of LI-RADS Version 2018
2019
Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity
2005
Keratin-Like Proteins in Normal and Neoplastic Cells of Human and Rat Mammary Gland as Revealed by Immunofluorescence Microscopy
1981
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
2002 StandoutScience
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Characterization of a Helicobacter pylori neutrophil-activating protein
1995
Comparison of Different Criteria for Interpretation of Immunoglobulin G Immunoblotting Results for Diagnosis of Helicobacter pylori Infection
2004
Helicobacter pylori Adhesin Binding Fucosylated Histo-Blood Group Antigens Revealed by Retagging
1998 StandoutScience
Advances in Synthetic Applications of Hypervalent Iodine Compounds
2016 Standout
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
The gastric marginal zone B-cell lymphoma of MALT type
2000
The effect of silymarin on plasma levels of malon-dialdehyde in patients receiving long-term treatment with psychotropic drugs
1994
Pathogenic role of hepatitis B virus in hepatitis B surface antigen—negative decompensated cirrhosis
1995
Hepatitis B Virus Replication and Liver Disease Progression: The Impact of Antiviral Therapy
2006
An Unusual Type of Cytokeratin Filament in Cells of a Human Cloacogenic Carcinoma Derived from the Anorectal Transition Zone
1982
High Relapse Rate in Patients with MALT Lymphoma Warrants Lifelong Follow-up
2005
The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells
1982 Standout
Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains.
1994
Inflammatory Exposure and Historical Changes in Human Life-Spans
2004 StandoutScience
Works of B Dragosics being referenced
Peripheral T-cell lymphomas of the intestine.
1992
Helicobacter pylori reinfection with identical organisms: transmission by the patients' spouses.
1995
Blood groups Lewis(b) and ABH expression in gastric mucosa: lack of inter-relation with Helicobacter pylori colonisation and occurrence of gastric MALT lymphoma.
1997
Double‐blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome
1997
Primary gastric B-Cell lymphoma: Results of a prospective multicenter study
2000
Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: Factors relevant to prognosis
1992
Effect of Ranitidine and Amoxicillin plus Metronidazole on the Eradication of Helicobacter pylori and the Recurrence of Duodenal Ulcer
1993
Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver
1989 Standout
Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma
2000
Kinetics of Specific IgG Antibodies for Monitoring the Effect of Anti-Helicobacter pylori Chemotherapy
1993
Wilson's disease in patients presenting with liver disease: A diagnostic challenge
1997
Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease
2001
Long-term follow-up study of asymptomatic hbsag-positive voluntary blood donors in austria: A clinical and histologic evaluation of 242 cases
1987
Primary prophylaxis of NSAID-induced gastroduodenal ulcers and dyspepsia in H. pylori (HP)-positive patients: Randomized, double-blind, placebo-controlled treatment of HP infection VS. omeprazole
2000
Primary gastrointestinal non-Hodgkin's lymphomas. A retrospective clinicopathologic study of 150 cases
1985
Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.
1997
Relative incidence of primary liver cancer in cirrhosis in Austria. Etiological considerations
1984
Novel Real-Time PCR Assay for Detection of Helicobacter pylori Infection and Simultaneous Clarithromycin Susceptibility Testing of Stool and Biopsy Specimens
2004
High-dose omeprazole/amoxicillin therapy versus quadruple therapy for treatment of Helicobacter pylori resistent against both metronidazole and clarthromycin — A prospective, randomized cross-over study
2001
Pathology of cytoskeleton of liver cells: Demonstration of mallory bodies (alcoholic hyalin) in murine and human hepatocytes by immunofluorescence microscopy using antibodies to cytokeratin polypeptides from hepatocytes
1981